Arno starts Phase II testing of onapristone in men with CRPC

According to a media release issued yesterday, Arno Therapeutics has  moved its investigational drug onapristone into the Phase II part of its initial Phase I/II clinical trial in the treatment of very late stage prostate cancer. … READ MORE …